Kahr Medical

Updated: October 28, 2025

Yaron Pereg - CEO

Country: Israel | Funding: $101.5M (+)

Website: https://kahrbio.com/

KAHR Medical develops novel fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases.

Competitors